John A. Flygare
Merck & Co., Inc., Rahway, NJ, USA (United States) · 100 works · 6,753 citations · h-index 37
Top works
- IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis
- P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro
- Novel antibody–antibiotic conjugate eliminates intracellular S. aureus
- A novel ruthenium-catalyzed tandem cyclization-reconstitutive addition of propargyl alcohols with allyl alcohols
- Solid-Phase Synthesis of 2-Aminothiazoles
- Structure-guided design of a selective BCL-XL inhibitor
- Design, Synthesis, and Biological Activity of a Potent Smac Mimetic That Sensitizes Cancer Cells to Apoptosis by Antagonizing IAPs
- Antibody‐Drug Conjugates for the Treatment of Cancer
- Discovery of a Potent and Selective BCL-X L Inhibitor with in Vivo Activity
- A Practical Synthesis of Rosefuran. Furans from Acetylenes and Allyl Alcohols
- Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152)
- A synthesis of the spiroketal subunit of (−)-calyculin A
- Targeting LGR5 + cells with an antibody-drug conjugate for the treatment of colon cancer
- A Novel Anti-CD22 Anthracycline-Based Antibody–Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs
- Solid-phase synthesis of disubstituted guanidines
- Recent Studies on the Peterson Olefination Reaction
- Structure and Function Analysis of Peptide Antagonists of Melanoma Inhibitor of Apoptosis (ML-IAP)
- Targeted drug delivery through the traceless release of tertiary and heteroaryl amines from antibody–drug conjugates
- Triply convergent, stereospecific alkene formation via Peterson olefination
- Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates